Study guide

3.2 Semisolid Dosage Forms

PTCB Nonsterile Compounding Certificate Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Regulations, Standards, and Governance

1.1 Federal Regulations Framework (FD&C Act, DQSA, Sections 503A vs 503B) 1.2 USP Standards & Applicability (<795>, <800>, <1163>) 1.3 Personnel Roles, Training, and Hygiene Standards 1.4 Documentation, Master Formulation Records, and Compounding Records

2 Chapter 2: Facilities, Material Management, and Stability

2.1 Facilities, Environmental Controls, and Equipment 2.2 Material Sourcing, Component Selection & Inventory Controls 2.3 Beyond-Use Dates (BUDs), Stability & Packaging

3 Chapter 3: Nonsterile Dosage Forms & Formulations

3.1 Solid Dosage Forms & Compounding 3.2 Semisolid Dosage Forms 3.3 Liquid Dosage Forms 3.4 Specialized Topical & Transdermal Formulations

4 Chapter 4: Equipment, Utensils, and Processing Tools

4.1 Weighing and Volumetric Equipment 4.2 Mixing and Comminution Utensils

5 Chapter 5: Pharmaceutical Compounding Calculations

5.1 Weighing, Measuring, Aliquot Calculations, & Powder Volume Adjustments 5.2 Concentration, Alligation, Dilution, & Dosing Calculations

6 Chapter 6: Compounding Procedures, Garbing, and Hazardous Drug Safety

6.1 Garbing, Hand Hygiene, and Personal Protective Equipment for Nonsterile Compounding 6.2 Hazardous Drug Handling and USP <800> Compliance in Nonsterile Compounding 6.3 Packaging, Container-Closure Systems, Storage, and Quality Assurance

7 Chapter 7: Quality Assurance, Sanitation, and Risk Management

7.1 Cleaning, Sanitizing, and Facility Sanitation Protocols 7.2 Environmental Monitoring, Equipment Calibration, and Maintenance 7.3 Quality Control, Product Verification, and Release Testing 7.4 Quality Assurance Systems, Customer Complaints, and Product Recalls

3.2 Semisolid Dosage Forms

Key Takeaways Explain This Topic AI

Ointment bases fall into four traditional classes: oleaginous, absorption (including anhydrous and W/O emulsion subtypes), water-removable O/W, and water-soluble.

Levigation with a compatible liquid (mineral oil for lipophilic bases, glycerin/propylene glycol for hydrophilic bases) reduces powder particle size and prevents grittiness in semisolids.

Gels rely on gelling agents like carbomers (requiring pH neutralization to form a matrix), cellulose polymers, or Poloxamers (showing reverse thermal gelation: liquid when refrigerated, gel at body temperature).

Suppository formulation requires mold calibration and Density Factor (DF) calculations (DF = B / [A - C + B]) to compensate for base displacement by active ingredients.

Cocoa butter (Theobroma oil) exhibits polymorphism; overheating above 35°C forms metastable alpha/gamma crystals that fail to solidify properly at room temperature.

Last updated: August 2026

3.2 Semisolid Dosage Forms

Semisolid dosage forms encompass topically and mucosally applied preparations, including ointments, creams, gels, pastes, and suppositories. They serve as protective barriers, therapeutic emollients, or vehicles for localized and systemic drug absorption. Understanding base chemistry, rheological properties, levigation mechanics, and mold calibration is essential for extemporaneous semisolid compounding.

Classification of Ointment Bases

Ointment bases are traditionally organized into four classes: oleaginous, absorption, water-removable, and water-soluble. The teaching table separates anhydrous absorption bases from water-in-oil emulsion absorption bases to make their behavior clear; those are two subtypes of the same absorption class, not a fifth official class.

Base Category Water Content Washability Occlusiveness Examples Key Clinical & Compounding Features

Oleaginous (class 1) Anhydrous Non-washable Maximum White Petrolatum, Yellow Ointment Hydrophobic, emollient, highly occlusive; prevents epidermal water loss; difficult to wash off.

Absorption—anhydrous subtype (class 2) Anhydrous Non-washable High Anhydrous Lanolin, Aquaphor, Hydrophilic Petrolatum Can absorb 2–3 times their weight in water to form W/O emulsions; useful for incorporating aqueous drug solutions.

Absorption—W/O emulsion subtype (class 2) Contains Water Non-washable / Poor Medium-High Cold Cream, Rose Water Ointment, Hydrous Lanolin Emollient, creamy texture; absorbs additional small amounts of aqueous fluids; provides protective barrier.

Water-removable O/W (class 3) Contains Water Water-washable Low Hydrophilic Ointment, Vanishing Cream Non-greasy, elegant, easily washed from skin and clothing; ideal for cosmetic and acute moist dermatoses.

Water-soluble (class 4) Anhydrous or Hydrous Completely washable None Polyethylene Glycol (PEG) Ointment Lipid-free blend of low and high MW PEGs (e.g., PEG 400 + PEG 3350); absorbs water; ideal for non-greasy topical applications.

  • Compounding Semisolids: Incorporation & Fusion Methods
  • Incorporation & Levigation

Incorporation involves mixing insoluble solid powders or liquid ingredients directly into a pre-formed base using an ointment slab (tile) and a flexible stainless steel or hard rubber spatula.

Levigation: Powdered active ingredients must be levigated with a suitable liquid agent prior to incorporation into the base to eliminate particle grittiness and ensure uniform dispersion.

Selecting Levigating Agents: The levigating agent must be physically and chemically compatible with the active drug and base:

For Oleaginous, Absorption, and W/O bases : Use Mineral Oil or liquid petrolatum.

For O/W Creams and Water-Soluble bases : Use Glycerin , Propylene Glycol , or PEG 400 .

Levigation Volume Rule: The volume of levigating agent used should be kept to the absolute minimum necessary (typically equal to 0.5 to 1.0 times the weight of the powder mass) to avoid thinning or liquefying the final semisolid base.

Fusion Method

Fusion is employed when the base contains solid high-melting-point components such as natural waxes, cetyl alcohol, paraffin, or high-molecular-weight PEGs.

Melt the ingredients with the highest melting points first in a porcelain dish or beaker over a water bath (e.g., beeswax at ~62–65°C).

Add components with lower melting points in decreasing order of melting temperature.

Slowly add heat-labile APIs or volatile components after cooling the melt to approximately 40–45°C.

Stir the mixture gently and continuously until congealed to prevent phase separation or crystalline precipitation.

  • Rheology of Gels & Pastes
  • Gels (Jellies)

Gels are semisolid systems consisting of dispersions of small or large molecules in an aqueous liquid vehicle rendered jelly-like by the addition of a gelling agent.

Carbomer Gels (Carbopol): Synthetic high-molecular-weight acrylic acid polymers. Un-neutralized carbomer dispersions are acidic (pH 2.8–3.2) and low viscosity. Adding a neutralizer such as Triethanolamine (TEA) or Sodium Hydroxide (NaOH) neutralizes the carboxyl groups, causing electrostatic repulsion that uncoils polymer chains into a clear, thick, high-viscosity matrix between pH 6.0 and 11.0.

Cellulose Gels: Methylcellulose, Hydroxypropyl methylcellulose (HPMC), and Sodium carboxymethylcellulose (NaCMC). Methylcellulose dissolves best in cold water after initial hydration in hot water (thermal gelation inversion).

Poloxamer (Pluronic) Gels: Polyoxyethylene-polyoxypropylene block copolymers (e.g., Pluronic F-127). Display reverse thermal gelation : free-flowing liquids at refrigerated temperatures (2–8°C) that transition into firm clear gels at room/body temperatures (20–37°C).

Pastes

Pastes are stiff semisolid preparations containing a high proportion of finely divided solid powders (typically 20% to 50% w/w ) dispersed in an ointment base (e.g., Zinc Oxide Paste USP , containing 25% zinc oxide and 25% starch in white petrolatum). Pastes remain in place where applied, absorb serous secretions, and form an opaque protective barrier.

Suppositories & Pessaries: Mold Calibration & Density Factors

Suppositories are solid dosage forms designed for insertion into bodily orifices (rectal, vaginal/pessaries, urethral/bougies) where they melt or dissolve to exert local or systemic effects.

Suppository Bases

Fatty / Oleaginous Bases:

Cocoa Butter (Theobroma Oil): Triglyceride base melting at body temperature (34–35°C). Displays polymorphism : overheating above 35°C during melting converts stable beta crystals into unstable alpha (mp ~22°C) or gamma (mp ~18°C) forms that fail to solidify at room temperature.

Synthetic Fatty Bases: Fattibase, Wecobee, Witepsol. Blends of hydrogenated vegetable oils that eliminate polymorphism risks and provide uniform solidification.

Water-Soluble / Miscible Bases:

Glycerinated Gelatin: Gelatin (20%), Glycerin (70%), Water (10%). Slow-dissolving base preferred for vaginal pessaries.

Polyethylene Glycol (PEG) Blends: Blends of PEG 400, 1450, and 8000. Do not melt at body temp but dissolve in mucous secretions. Higher melting point (>37°C) permits storage at room temperature without refrigeration.

Mold Calibration & Density Factor Calculations

Because APIs have different densities than suppository bases, adding a drug displaces a specific volume of base. Suppository molds are calibrated by volume, but components are weighed by mass. Technicians must calculate the Density Factor (DF) of the drug relative to the base.

Density Factor Equation:

  • DF = B / (A - C + B)
  • A = Average weight of blank suppository shell (g)
  • B = Weight of active drug per suppository (g)
  • C = Average weight of medicated suppository (g)

Total Base Weight Required Equation:

Weight of Base Required = (N * A) - [ (N * B) / DF ]

N = Number of suppositories to compound (plus overage, typically +10–20%).

  • Worked Numerical Examples
  • Worked Example 1: Suppository Mold Displacement & Base Calculation

Scenario: A technician is asked to compound 12 Indomethacin 50 mg rectal suppositories using Fattibase in a nominal 2.0 g suppository mold. Mold calibration reveals that the average blank suppository weight ( A ) is 2.00 g. A test batch of medicated suppositories containing 50 mg indomethacin weighs an average ( C ) of 2.03 g per suppository. Calculate the Density Factor of indomethacin and the total mass of Fattibase needed for 14 suppositories (including overage).

Solution Steps:

Identify parameters:

  • A (blank weight) = 2.00 g
  • B (drug dose) = 50 mg = 0.050 g
  • C (medicated weight) = 2.03 g
  • N = 14 suppositories

Calculate Density Factor (DF):

  • DF = B / (A - C + B)
  • DF = 0.050 / (2.00 - 2.03 + 0.050)
  • DF = 0.050 / (-0.03 + 0.050) = 0.050 / 0.020 = 2.50 (Indomethacin is 2.5 times denser than Fattibase)

Calculate total drug required for 14 suppositories:

Total Drug = 14 * 0.050 g = 0.700 g Indomethacin

Calculate base displaced by drug:

Base Displaced = Total Drug / DF = 0.700 g / 2.50 = 0.280 g base displaced

Calculate total Fattibase required:

  • Total Blank Base Mass = 14 * 2.00 g = 28.00 g
  • Net Base Required = 28.00 g - 0.280 g = 27.72 g Fattibase

Compounding Summary: Melt 27.72 g Fattibase over a water bath (<45°C), incorporate 0.700 g finely triturated indomethacin, pour into mold cavities, cool, trim, and package.

Worked Example 2: Topical Ointment Levigation & Incorporation Calculation

Scenario: Compound 60 g of Hydrocortisone 1% and Salicylic Acid 2% Ointment in a White Petrolatum base. Calculate the masses of APIs, levigating agent (mineral oil), and base required.

Solution Steps:

Calculate active ingredient masses:

  • Hydrocortisone API = 60 g * 0.01 = 0.60 g
  • Salicylic Acid API = 60 g * 0.02 = 1.20 g
  • Total Powder Mass = 0.60 g + 1.20 g = 1.80 g

Calculate mineral oil levigating agent mass (1:1 ratio with powder):

  • Mineral Oil Mass = 1.80 g (approx. 2.0 mL based on density 0.88 g/mL = 1.76 g)
  • Use 1.80 g Mineral Oil

Calculate White Petrolatum base required:

  • Base Required = Total Weight - (Powder Mass + Levigating Agent Mass)
  • Base Required = 60.0 g - (1.80 g + 1.80 g) = 60.0 g - 3.60 g = 56.40 g White Petrolatum

Compounding Procedure: Levigate hydrocortisone and salicylic acid with 1.80 g mineral oil on an ointment tile until smooth. Geometrically incorporate 56.40 g White Petrolatum. Package in a 2 oz ointment jar.

Loading diagram... Suppository Compounding & Mold Density Factor Workflow

Characteristics of Ointment Bases: Water Absorption Capacity (% of Base Weight)